Nutra Pharma Corporation Company Profile

News Articles [ 1204 Associated News Articles listed on BioPortfolio]

Nutra Pharma Provides Sales and Marketing Update

Nutra Pharma is providing an update on the sales and marketing efforts of TCN as they begin their global marketing campaign for Nutra Pharma's over-the-counter (OTC) pain reliever, Nyloxin™ COR...

Nutra Pharma Introduces Nyloxin(TM) Military Strength

CORAL SPRINGS, Fla., Dec. 19, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Scleros...

Nutra Pharma Begins Marketing Nyloxin(TM) Through Direct Distributors

CORAL SPRINGS, Fla., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (Pink Sheets:NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodef...

Nutra Pharma Patent and Trademarks Published in India

CORAL SPRINGS, Fla., March 25, 2013 /PRNewswire/ -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficien...

Pro-Nutra and GNC Partner to Launch an Exclusive Line of Physician Recommended Products

Pro-Nutra represents a premier, high-end, diet and energy line Ft. Lauderdale, FL (PRWEB) May 30, 2012 BPI Sports, a leader in the sports nutrition industry, announced today the launch of Pro-Nutra....

The Magic Weight Loss Cure for Every Body Type - 20% OFF For a Limited Time!

SEATTLE, May 14, 2013 /PRNewswire-iReach/ -- "Green Bean Ketone Extreme" goes one step further. Researchers at Forefront Nutra were able to crack the synergistic code. Synergism is the effect that eac...

Divine Skin Secures Exclusive Rights to Nutra Origin Nutraceutical Supplements Line Further Expanding Into $176 Billion Market

MIAMI BEACH, Fla., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Divine Skin Inc., (OTCBB: DSKX) a leading developer and formulator of personal care products, today announced that through its wholly owned subsid...

Pharma 3.0 Pulls Companies into the Digital Future

Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0.  Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...

Drugs and Medications [ 238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [ 56 Associated PubMed Articles listed on BioPortfolio]

Comment about the article "Psychopharmaceuticals and diabetes" of Ress C, Tschoner A, Kaser S, and Ebenbichler CF in Wiener Medizinische Wochenschrift 2011; 161/21-22: 531-42.

Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.

Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...

Is pharma running out of brainy ideas?

Big pharma moves from 'blockbusters' to 'niche busters'.

China spurs pharma innovation.

Clinical Trials [ 35 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

This is 2-armed parallel group, prospective, randomized, open-label, multicenter Phase 3 controlled trial to establish the efficacy and safety of conversion from maintenance immunosuppress...

Development of a New Method for Analgesia

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

Companies [ 593 Associated Companies listed on BioPortfolio]

Nutra Pharma Corp.

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the...

Stevia Nutra Corporation

Stevia Nutra is an Agro-Management company focused on stevia agronomics which includes plant breeding, proprietary agricultural practices and post-harvest techniques. Stevia Nutra...

Nutra Pharma Corporation

Nutra Pharma Corp. (OTCBB: NPHC) is a biopharmaceutical company specializing in the acquisition, licensing and commercialization of pharmaceutical products and technologies for the management of neuro...

Nutra Summa

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and...